Illumina Shares Up 11 Percent on Strong Q1 Financials, Increased Guidance | GenomeWeb

NEW YORK, April 19 (GenomeWeb News) - Shares in Illumina were up 10.95 percent, or $2.82, at $28.57 -- a new 52-week high -- in mid-afternoon trading after the company yesterday reported a 93-percent increase in first-quarter revenues and increased its 2006 outlook.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.